Epidemic Research Center
The Epidemic Research Center at Rambam was established during the first wave of the Covid-19 pandemic in order to actively help fight the virus. The Center is adjacent to Rambam’s BioBank and makes extensive use of this unique resource. The BioBank is a large collection of various samples collected from patients and functions as a database of biomaterial samples that match the biological material with clinical and epidemiological information. It is the largest repository in Israel for biological samples collected from Covid-19 patients, among others.
The Epidemic Research Center consists of a team of leading researchers experienced in the fields of microorganisms and plagues, working in one large lab. They conduct intensive studies based on the BioBank’s samples as well as clinical data. As part of the Rambam Healthcare Campus – one of the largest and most innovative hospitals in Israel – the Center enjoys close collaboration with Rambam’s numerous topnotch clinicians and scientists.
The research covers all fields related to epidemics in general and to Covid-19 in particular, including diagnostics and the development of therapeutics and medical devices. The lab works under a stringent BSL-2+ (Biosafety Level Two Plus) protocol, which enables the handling of infectious agents.
The Center has formed partnerships with academic institutions, private companies and government entities. In fact, it has been designated the leading coronavirus research lab for Israel’s Ministry of Defense and is tasked with carrying out all of the Ministry’s Covid-related studies.
Throughout the Covid-19 crisis, Rambam’s Epidemic Research Center has been engaged in extremely intensive research and its scientists have been working around the clock as part of global efforts to combat the pandemic. These efforts are bearing fruit, with important innovations at various stages of development. Once the current crisis will be resolved, the Center will continue studying plagues in order to be better prepared for – and hopefully stave off – future epidemics.
Contact information: Dr. Shlomit Yehudai-Reshef
Email: [email protected]